ProQR Therapeutics N.V. ( PRQR) - Key Metrics
PRQR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.05 | -$0.09 | -$0.13 | -$0.13 |
| 2025Q3 | $0.03 | -$0.10 | -$0.12 | -$0.12 |
| 2025Q2 | $0.04 | -$0.12 | -$0.11 | -$0.11 |
| 2025Q1 | $0.04 | -$0.10 | -$0.15 | -$0.15 |
PRQR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -5.01 |
| 2025Q3 | ? | -4.34 |
| 2025Q2 | ? | -3.74 |
| 2025Q1 | ? | -3.21 |
PRQR
Price: $1.50
52 week price:
Earnings Per Share: -0.50 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Netherlands
Volume: 1.0 million
Ebitda: -11.0 millionMarket Capitalization: 161.2 million